S100A7 and squamous cell carcinoma: Aiming to establish biomarkers for bladder cancers, research led by Celis [106] and Ostergaard [107] reported increased levels of Psoriasin (also known as S100A7) in squamous cell carcinomas (SCCs) and urine samples from cancer patients.